| Literature DB >> 34283343 |
Doriana Landi1,2, Marta Ponzano3, Carolina Gabri Nicoletti4,5, Gaia Cola4,5, Gianluca Cecchi4,5, Alfonso Grimaldi4, Giorgia Mataluni4, Nicola Biagio Mercuri4,5, Maria Pia Sormani3, Guglielmo Pacileo6, Girolama Alessandra Marfia4,5,7.
Abstract
Restrictions in the access to healthcare facilities during COVID-19 pandemic have raised the need for remote monitoring of chronic medical conditions, including multiple sclerosis (MS). In order to enable the continuity of care in these circumstances, many telemedicine applications are currently tested. While physicians' preferences are commonly investigated, data regarding the patients' point of view are still lacking. We built a 37 items web-based survey exploring patients' propensity, awareness, and opinions on telemedicine with the aim to evaluate the sustainability of this approach in MS. Analysing 613 questionnaires out of 1093 that were sent to persons with MS followed at the Multiple Sclerosis Center of Tor Vergata University, Rome, we found that more than half of respondents (54%) were open to having a televisit. Propensity toward telemedicine significantly depended on having a higher income (p = 0.037), living farther from the center (p = 0.038), using computer and tablet (p = 0.010) and using the Internet for other remote activities (p < 0.001), conversely it was not influenced by any specific disease characteristics (i.e. degree of disability). The main advantages and disadvantages of televisit reported by participants were respectively saving time (70%) and impossibility to measure physical parameters (71%). Although the majority of respondents are in favour of televisit, so far this approach is restricted to those displaying better socioeconomic conditions and higher familiarity with technology. Implications of the study are that telemedicine platforms should be better tailored to patients' demands in order to spread the use of telemedicine, to enhance usability and to increase patients' adherence.Entities:
Keywords: COVID-19 pandemic; Multiple sclerosis; Remote monitoring; Survey; Telemedicine; Televisit
Mesh:
Year: 2021 PMID: 34283343 PMCID: PMC8289711 DOI: 10.1007/s10072-021-05398-6
Source DB: PubMed Journal: Neurol Sci ISSN: 1590-1874 Impact factor: 3.307
Fig. 1Propensity to televisit among those persons with MS completing the survey
Demographic characteristics of responders and univariable/multivariable logistic regression models for the propensity to telemedicine. ** Logistic Regression model estimates refer to the change in the interest to telemedicine due to a unit class increase in the independent variable
| Sociodemographic characteristics | Uni OR (95% CI) | Multi OR (95% CI) | |||
|---|---|---|---|---|---|
| Sex, N (%) | |||||
| Male | 170 (30%) | 1.15 (0.80–1.66) | 0.439 | ||
| Female | 400 (70%) | 1.00 (ref) | -—- | ||
| Age, N (%) | |||||
| 18–30 years | 50 (9%) | ||||
| 31–40 years | 138 (24%) | -—- | -—- | ||
| 41–50 years | 185 (32%) | -—- | -—- | ||
| 51–60 years | 132 (23%) | -—- | -—- | ||
| 61–70 years | 57 (10%) | -—- | -—- | ||
| > 70 years | 8 (1%) | 0.94 (0.81–1.08) | 0.365** | ||
| Education, N (%) | |||||
| Elementary school | 7 (1%) | -—- | -—- | ||
| Middle school | 80 (14%) | -—- | -—- | ||
| Secondary school | 289 (51%) | -—- | -—- | ||
| Degree | 153 (27%) | -—- | -—- | ||
| Postgraduate education | 41 (7%) | 1.83 (1.46–2.27)** | < 0.001** | 1.59 (1.25–2.02)** | < 0.001** |
| Occupational status | |||||
| Unemployed | 110 (20%) | 1.00 (ref) | -—- | ||
| Retired | 98 (18%) | 1.10 (0.63–1.90) | 0.741 | 0.85(0.46–1.57) | 0.598 |
| Student | 19(3%) | 1.78 (0.66–4.76) | 0.253 | 1.20 (0.43–3.36) | 0.725 |
| Self-employed | 61(11%) | 1.99 (1.05–3.77) | 0.034 | 0.99 (0.48–2.04) | 0.974 |
| Employed | 272(49%) | 2.45 (1.56–3.84) | < 0.001 | 1.34 (0.76–2.38) | 0.315 |
| Contract type, N (%) | |||||
| Part-time | 68 (22%) | 1.00 (ref) | |||
| Full-time | 243 (78%) | 1.01 (0.58–1.76) | 0.983 | ||
| Income, N (%) | |||||
| No income | 84 (15%) | -—- | -—- | ||
| Low | 174 (31%) | -—- | -—- | ||
| Medium | 294 (52%) | -—- | -—- | ||
| High | 18 (3%) | 1.65 (1.32–2.06) ** | < 0.001** | 1.38 (1.04–1.83)** | 0.027** |
MS characteristics of responders and univariable/multivariable logistic regression models for the propensity to telemedicine. ** Logistic Regression model estimates refer to the change in the interest to telemedicine due to a unit class increase in the independent variable
| MS characteristics | OR (95% CI) | ||
|---|---|---|---|
| Mobility, N (%) | |||
| Without help | 397 (75%) | 1.00 (ref) | -—- |
| Unilateral assistance | 64 (12%) | 0.70 (0.41–1.18) | 0.181 |
| Bilateral assistance | 31 (6%) | 0.85 (0.40–1.78) | 0.667 |
| Wheelchair use | 36 (7%) | 1.23 (0.60–2.53) | 0.578 |
| Therapy, N (%) | |||
| No | 86 (16%) | 1.43 (0.88– 2.34) | 0.147 |
| Yes | 457 (84%) | 1.00 (ref) | -—- |
| Disease duration, N (%) | |||
| < 1 year | 19 (3%) | -—- | -—- |
| 1–4 years | 95 (17%) | -—- | -—- |
| 5–9 years | 140 (26%) | -—- | -—- |
| 10–19 years | 220 (41%) | -—- | -—- |
| ≥ 20 years | 69 (13%) | 1.02 (0.86–1.20) ** | 0.859** |
Characteristics of the Responders’ access to the MS center and univariable/multivariable logistic regression models for the propensity to telemedicine. ** Logistic Regression model estimates refer to the change in the interest to telemedicine due to a unit class increase in the independent variable
| Logistic characteristics | |||||
|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | ||||
| Distance from the MS center, N (%) | |||||
| < 10 km | 99 (18%) | -—- | -—- | ||
| 10–50 km | 302 (56%) | -—- | -—- | ||
| 50–100 km | 86 (16%) | -—- | -—- | ||
| > 100 km | 56 (10%) | 1.21 (0.98–1.48)** | 0.076** | 1.26 (1.02–1.56)** | 0.032** |
| Time required, N (%) | |||||
| < 1 h | 62 (12%) | -—- | -—- | ||
| 1–2 h | 172 (32%) | -—- | -—- | ||
| 3–4 h | 224 (42%) | -—- | -—- | ||
| > 4 h | 80 (15%) | 1.02 (0.83–1.24)** | 0.865** | ||
| Time off work, N (%) | |||||
| No | 146 (39%) | 1.00 (ref) | -—- | ||
| Yes, ½ day | 75 (20%) | 1.01 (0.56–1.82) | 0.969 | ||
| Yes, 1 day | 144 (39%) | 1.22 (0.75–1.99) | 0.428 | ||
| Yes, > 1 day | 6(2%) | 2.68 (0.31–23.60) | 0.373 | ||
| Accompanying person, N (%) | |||||
| No | 111 (21%) | 1.99 (1.16–3.40) | 0.012 | 2.13 (1.23–3.66) | 0.007 |
| Yes, but not necessary/sometimes | 305 (57%) | 1.37 (0.90–2.09) | 0.145 | 1.38 (0.90–2.11) | 0.139 |
| Yes, help necessary | 122 (23%) | 1.00 (ref) | -—- | 1.00(ref) | -—- |
| Mean of transportation used to reach the center, N (%) | |||||
| Private | 467 (87%) | 1.00 (ref) | -—- | ||
| Public | 69 (13%) | 1.31 (0.77–2.24) | 0.319 | ||
Responders’ attitude towards the use of Internet and technologies and univariable/multivariable logistic regression models for the propensity to telemedicine
| Internet and technologies characteristics | OR (95% CI) | OR (95% CI) | |||
|---|---|---|---|---|---|
| Internet available at home, N (%) | |||||
| Yes | 491(92%) | 2.32 (1.25–4.32) | 0.008 | 1.28(0.55–2.96) | 0.568 |
| No | 45(8%) | 1.00(ref) | -—- | ||
| Habitual use of Internet, N (%) | |||||
| Yes | 501 (94%) | 3.82 (1.77–8.25) | 0.001 | 0.68 (0.24–1.88) | 0.453 |
| No | 32 (6%) | 1.00 (ref) | -—- | ||
| Technologies used, N (%) | |||||
| None or only smartphone | 220 (36%) | 1.00 (ref) | -—- | ||
| Also tablet or/and computers | 393 (64%) | 6.82 (4.70–9.91) | < 0.001 | 1.90 (1.06–3.38) | 0.003 |
| Use of Internet for remote activities, N (%) | |||||
| No | 213 (41%) | 1.00 (ref) | -—- | ||
| Yes | 312 (59%) | 4.40 (3.02–6.41) | < 0.001 | 3.09 (1.98–4.85) | < 0.001 |
| Use of Internet for medical information, N (%) | |||||
| No | 66 (13%) | 1.00 (ref) | -—- | ||
| Yes | 459 (87%) | 1.68 (1.00–2.82) | 0.051 | 1.37 (0.72–2.58) | 0.335 |
| Use of e-mail, N (%) | |||||
| No | 54 (10%) | 1.00 (ref) | -—- | ||
| Yes | 471 (90%) | 4.23 (2.31–7.75) | < 0.001 | 1.80 (0.80–4.04) | 0.154 |
| Use of technologies to monitor workout performance | |||||
| No | 406 (86%) | 1.00 (ref) | -—- | ||
| Yes | 68 (14%) | 2.07 (1.14–3.75) | 0.016 | 1.27 (0.67–2.40) | 0.468 |
Responder’s knowledge and opinions about telemedicine
| Telemedicine knowledge and general opinion | |
|---|---|
| Knowledge of the telemedicine before the COVID-19 pandemic, N (%) | |
| Yes | 225 (43%) |
| No | 300 (57%) |
| Main advantage of telemedicine, N (%) | |
| Saving time | 327 (70%) |
| Saving money | 47 (10%) |
| No accompanying persons needed | 91 (20%) |
| Main disadvantage of telemedicine, N (%) | |
| Difficulties in using technologies due to MS | 27 (6%) |
| Difficulties in using technologies in general | 40 (8%) |
| Lack of technological support | 6 (1%) |
| Difficulties in fully explaining health problems | 64 (14%) |
| No possibility of assessing neurological status | 337 (71%) |
| 0–4 score evaluation of utility and completeness of telemedicine, mean (SD) | 2.1 (1.0) |
| Preference of telemedicine compared to telephone contact, N (%) | |
| Yes | 278 (82%) |
| No | 62 (18%) |
| Preference of telemedicine compared to visits at the center, N (%) | |
| Yes, always | 10 (2%) |
| Yes, but periodically | 78 (17%) |
| Yes, but occasionally | 231 (51%) |
| No | 138 (30%) |
| When telemedicine can replace visits at the center | |
| Normal FU for exams monitoring, N (%) | 251 (81%) |
| Assistance for the onset of a new symptom or for urgences, N (%) | 132 (43%) |
| Evaluation of therapy change, N (%) | 95 (31%) |
| Multidisciplinary visit, N (%) | 52 (17%) |
| For patients from a different region, N (%) | 113 (37%) |
| For patients with mobility problems, N (%) | 131 (42%) |
| Open to use technologies to evaluate neurological measurements during a telemedicine visit, N (%) | |
| No | 132 (28%) |
| It depends on the cost and on difficulty in their use | 120 (25%) |
| Yes | 222 (47%) |
| Open to use a Web App to update personal information, information about therapies, exams and visits reports, N (%) | |
| No | 54 (14%) |
| Yes | 321 (86%) |
| Evaluation of telemedicine, if experienced, N (%) | |
| Not able to connect | 33 (52%) |
| Assistance needed | 4 (6%) |
| Some problems but solved in autonomy | 6 (9%) |
| No problems | 21 (33%) |
| 0–10 score evaluation of telemedicine, if experienced, mean (SD) | 6.7 (2.9) |